Pausetiv is the first Italian digital platform dedicated exclusively to menopause care. Born from a multidisciplinary team and supported by a high-level scientific committee.

Pausetiv's clinical model is based on the guidelines of the leading international scientific societies and is validated by a multidisciplinary scientific committee. The platform integrates medicine, lifestyle and technology to deliver continuous, personalized care in real time.

ZNEXT is backing Pausetiv as co-founder with an initial pre-seed investment of €150,000, ongoing operational support, access to specialized expertise, and the Group's network.

“With Pausetiv, we want to turn menopause into a concrete opportunity for personalized care, not a fate to endure in silence. Our goal is to offer effective, science-based tools to both women and healthcare professionals, closing a still enormous gap in gender medicine.
Thanks to technology, we are able to support clinicians with automated reports, continuous symptom monitoring and centralized data collection, increasing efficiency and enabling faster, more targeted therapeutic decisions. We believe in a more accessible, multidisciplinary and connected healthcare system, where digitalization enhances, and does not replace, the doctor-patient relationship.”
Clarice Pinto, Founder and CEO of Pausetiv